Affiliate disclosure
We earn a commission if you sign up with Trimi through the links on this page. It did not buy a favourable review. This is an updated version of our February 2026 review, rewritten after fresh research; the rating has moved because Trimi discloses considerably more than we previously credited it for, not because of the commission.
Trimi Health is a US telehealth service selling compounded GLP-1 medication — semaglutide at $99 a month and tirzepatide at $125 — with the price held flat at every dose and medication, clinician visits, ongoing check-ins and free overnight shipping bundled into one membership. It is aimed at cash-pay buyers who want a low, predictable price. What sets it apart from the rest of the budget end of this market is disclosure: Trimi names its compounding pharmacies, names the doctors running its clinical network, publishes nationwide coverage and states clearly that its products are not FDA-approved. What it lacks is history.
Overview
Trimi trades at trytrimi.com. Clinical care is delivered through Arora Health, a licensed US provider network, with Dr Sean Arora, MD named as medical director and Dr Shannon Arora, MD as chief medical officer. Coverage is all 50 states. Intake is asynchronous — no appointment to schedule — with submissions reviewed in 24 to 48 hours and approvals advertised within 24.
Medication is compounded by two named, state-licensed 503A pharmacies: VialsRx and GreenwichRx. Shipping is advertised as free overnight, with typical delivery in two to four days — a slight tension in the marketing worth noting, though not a serious one.
Trimi at a Glance
| Medications offered | Compounded semaglutide and compounded tirzepatide |
|---|---|
| Brand-name or compounded | Compounded only. Trimi states plainly that these are prepared per individual prescription and are not FDA-approved as drugs |
| Consultation process | Asynchronous online intake, no appointment needed; reviewed in 24–48 hours with approval advertised within 24 |
| Eligibility | Assessed at intake; specific BMI or comorbidity criteria are not published |
| Provider involvement | Licensed US providers through Arora Health; clinician visits and ongoing check-ins included in the membership |
| Lab requirements | Not stated as required |
| Pharmacy fulfillment | Named — VialsRx and GreenwichRx, both state-licensed 503A compounding pharmacies |
| Shipping frequency | Free overnight shipping advertised; typical delivery quoted as 2–4 days |
| Support services | Clinician visits and ongoing check-ins included in one flat membership |
| Membership fees | None on top — one membership covers medication, visits, check-ins and shipping |
| Medication fees | Compounded semaglutide $99/month and tirzepatide $125/month on annual plans, held flat at every dose |
| Cancellation policy | Not clearly published; the headline rates are annual-plan pricing |
| Refund policy | Follow the plan for six months without losing weight and you can request a refund, subject to published policy terms |
| Insurance | Not accepted |
| HSA/FSA | Not stated on the site |
| Availability | All 50 states, via the Arora Health provider network |
How It Works, Step by Step
- Online intake. A health questionnaire with no appointment to book.
- Clinician review. A licensed provider from the Arora Health network reviews your submission within 24 to 48 hours.
- Approval. Trimi advertises patient approval within 24 hours.
- Membership starts. One flat charge covering medication, clinician visits, check-ins and shipping.
- Compounding. VialsRx or GreenwichRx prepares the prescription.
- Delivery and follow-up. Free overnight shipping, then ongoing check-ins as you titrate — at the same price throughout.
Pricing and the Annual-Plan Catch
Prices below are from Trimi's own site on 6 August 2026.
| Medication | Price | Plan | Status |
|---|---|---|---|
| Compounded semaglutide | $99/month | Annual | Not FDA-approved |
| Compounded tirzepatide | $125/month | Annual | Not FDA-approved |
At $125 a month, Trimi's tirzepatide is among the cheapest we have catalogued — well under half what TrimRx charges at $349, and below Cora Health's $135 floor. The flat-dose commitment matters more on tirzepatide than anywhere else, because dose escalation on that drug is where costs usually run away.
These are annual-plan rates. Trimi quotes $99 and $125 against annual membership plans, and does not publish a month-to-month equivalent we could find. So the low price carries a twelve-month commitment.
That is the same structure we have flagged elsewhere, and the same caution applies: cancellation terms are not clearly published, and a year is a long time to commit to a compounded product while the FDA is actively narrowing what may be compounded. The refund undertaking below partially offsets it, but read that carefully too.
On refunds, Trimi's stated position is that if you follow your plan for six months and do not lose weight, you can request a refund. That is a real commitment and better than most, but note what it requires: six months of adherence before you can invoke it, with the terms set out in a separate refund policy. It is not a change-your-mind guarantee.
What Trimi Discloses That Others Do Not
This is the strongest part of Trimi's offer, and it is worth being specific about, because it is the opposite of the pattern we usually document.
- It names its pharmacies. VialsRx and GreenwichRx, both identified as state-licensed 503A compounding pharmacies. Most competitors at this price — WellMedr, Willow, MEDVi — do not.
- It names its clinicians. Arora Health as the provider network, with two named physicians in leadership roles you can look up.
- It publishes state coverage. All 50 states, stated plainly, rather than "we are expanding rapidly".
- It states the regulatory position correctly. Compounded semaglutide and tirzepatide are "prepared per individual prescription by a state-licensed pharmacy and are not FDA-approved as drugs" — which is exactly right, and exactly what the FDA has been sending warning letters about elsewhere.
Taken together that is the best disclosure profile of any sub-$150 provider on this site. It does not prove the medication is good, and it does not substitute for a track record. But it means you can actually check things — the pharmacy licences, the physicians' registrations — which is the minimum a buyer of a non-approved injectable should be able to do.
One Marketing Claim Worth Flagging
Trimi's promotional material describes its compounded products as containing "the same active ingredients found in Wegovy and Mounjaro". That framing needs care, and we are not going to repeat it as though it settled anything.
In February 2026 the FDA sent a warning letter to a competitor, MEDVi, specifically over the claims "Same active ingredient as Wegovy® and Ozempic®" and "Same active ingredient as Mounjaro® and Zepbound®". The agency's position was that "compounded drug products are not FDA-approved" and that such claims "imply that your products have been FDA-approved or otherwise evaluated for safety and effectiveness when they have not".
Sharing an active ingredient is not the same as being the same medicine. Formulation, concentration, excipients, sterility assurance and stability all differ, and none of it has been through FDA review. Trimi discloses the non-approval clearly elsewhere, which is more than MEDVi was doing — but the comparison framing is the industry's standard sales line, and a regulator has now said in writing what is wrong with it. Our compounded vs brand-name guide sets out the real differences.
Eligibility, Contraindications, and Side Effects
Trimi assesses eligibility at intake but does not publish BMI or comorbidity thresholds. It does publish nationwide coverage, which removes the most common practical obstacle. See our eligibility guide for what a thorough screen covers.
Semaglutide and tirzepatide carry a boxed warning regarding thyroid C-cell tumours, based on rodent studies. You should not take these medications if you or a family member have had medullary thyroid carcinoma, if you have Multiple Endocrine Neoplasia syndrome type 2, or if you have had a serious hypersensitivity reaction to the active ingredient. They are not for use in pregnancy. A history of pancreatitis, gallbladder disease, gastroparesis or other severe gastrointestinal disease, or diabetic retinopathy, warrants specific discussion first.
Common side effects are gastrointestinal — nausea, vomiting, diarrhoea, constipation and abdominal pain — typically worst after a dose increase. Serious but less common risks include pancreatitis, gallbladder disease and acute kidney injury caused by dehydration. An asynchronous intake model with no scheduled appointment means the burden of raising problems falls on you; use the included check-ins. See our side effects guide.
We are not quoting weight-loss figures for Trimi. It publishes no outcome data for its own patients, and trial results for brand-name products do not transfer to compounded preparations.
Legitimacy and a Very Small Review Sample
Trimi states it is LegitScript verified, and its structural disclosures — named pharmacies, named physicians, a real provider network — all check out as the kind of thing a legitimate operator publishes. We report the LegitScript status as a company claim we did not independently confirm.
The evidence base on customer experience is genuinely thin, and the summaries of it conflict. Trimi's Trustpilot sample runs to tens of reviews, not thousands. One third-party summary reports about 4.6 out of 5 with 86% five-star across roughly 44 reviews; another reports 3.5 out of 5 with 37% one-star; a third describes a bimodal split of roughly 59% five-star against 37% one-star.
We could not resolve the discrepancy at source. What all three agree on is that the sample is small and the distribution is polarised. At this size, a handful of reviews moves the average several tenths, and no reading of it should carry much weight either way. There is also no BBB profile for Trimi, so that check is unavailable entirely.
Where negative reports exist, the themes are the category standard: unauthorised billing changes, unresponsive customer service, and some concerns about medication. Nothing there is distinctive enough to weigh heavily given the sample size — but nor is the positive side, and that cuts both ways. Trimi is a company you would be judging on its disclosures rather than on its record, because there is not yet much record to judge.
Where Compounded GLP-1s Stand Right Now
Trimi is compounded-only, which makes the regulatory trajectory a business risk as well as a clinical one. Compounded semaglutide and tirzepatide are not FDA-approved, are not generics, and the brand-name approval does not extend to them.
The shortages that created this market ended with the FDA resolving the tirzepatide shortage in October 2024 and the semaglutide shortage on 21 February 2025. On 30 April 2026 the FDA proposed excluding semaglutide, tirzepatide and liraglutide from the 503B bulks list; the comment period closed on 30 July 2026. Trimi's named partners are 503A pharmacies rather than 503B outsourcing facilities, so that specific proposal does not target its supply route — but 503A pharmacies may not compound what is essentially a copy of a commercially available drug regularly or in inordinate amounts, and industry reporting through 2026 describes compounded tirzepatide supply in particular becoming harder to secure. On a twelve-month plan, that is a risk worth pricing in. Our compounded vs brand-name guide covers the trade-off.
How Trimi Compares
| Provider | Semaglutide | Tirzepatide | Names pharmacy | Review sample | Our rating |
|---|---|---|---|---|---|
| Trimi Health | $99 | $125 | Yes — two named 503A | Tens of reviews | 3.6 / 5 |
| Cora Health | $99–$175 | $135–$225 | Yes — PCAB-accredited | Established | 4.5 / 5 |
| Embody | $69 advertised | $119 | Yes — four named 503A | Thousands | 3.3 / 5 |
| Precision Telemed | $139.99 flat | $179.99 flat | Yes | Established | 4.4 / 5 |
On paper Trimi beats all three on tirzepatide price while matching them on pharmacy disclosure. The reason it does not out-rank Cora Health or Precision Telemed here is simply that they have demonstrated the service works at volume and Trimi has not yet. Against Embody, Trimi is more expensive on semaglutide but quotes a real price rather than a countdown-timer discount, and names its physicians as well as its pharmacies.
Pros and Cons
Pros
- Tirzepatide at $125 is among the cheapest we have catalogued
- Price held flat at every dose — no escalation as you titrate
- Names both compounding pharmacies, VialsRx and GreenwichRx
- Names its medical leadership and provider network
- Publishes coverage in all 50 states
- States the non-FDA-approved status of compounded products correctly
- One membership covers medication, clinician visits, check-ins and shipping
- Free overnight shipping advertised
- Approval advertised within 24 hours, no appointment needed
- Six-month refund undertaking if you do not lose weight
Cons
- Headline prices are annual-plan rates — a 12-month commitment
- No month-to-month price published
- Cancellation terms not clearly published
- Independent review sample is tens, not thousands
- Third-party summaries of that sample disagree sharply
- Reported one-star share as high as 37% in one summary
- No BBB profile at all — that check is unavailable
- The refund requires six months of adherence first
- Marketing uses the "same active ingredients" framing the FDA has objected to elsewhere
- Compounded only, with no brand-name fallback if supply tightens
- Eligibility criteria not published
- Insurance not accepted; HSA/FSA not addressed
Who Should Pick It, and Who Should Look Elsewhere
Trimi suits you if you want compounded tirzepatide at the lowest price available from a provider that will tell you who makes it, and you are comfortable being an early customer. The combination of $125 tirzepatide, flat dose pricing, named pharmacies and named physicians is not available anywhere else we have looked. If you are going to commit for a year, this is a better-disclosed place to do it than most.
Look elsewhere if you want a proven operator — Cora Health and Precision Telemed offer comparable disclosure with a real track record for a modest premium. Look elsewhere if you want to pay month-to-month, since Trimi's advertised rates are annual. And if you want an FDA-approved medication rather than a compounded one, NovoCare Pharmacy sells brand-name semaglutide at $149 — more than Trimi, but approved, and not exposed to compounding-supply risk.
Limitations of This Review
This review is based on Trimi's published materials and independent review coverage, checked on 6 August 2026. We were not able to load Trustpilot directly and the third-party summaries of Trimi's score disagree with each other; we have reported that disagreement rather than picking one. There is no BBB profile to check. Cancellation terms and a month-to-month price are not published. We have not signed up, been prescribed, or received medication, and we did not independently verify the LegitScript status, the pharmacy licences or the refund policy terms. Given how new this company is, treat everything here as a snapshot.
Frequently Asked Questions
How much does Trimi cost?
Compounded semaglutide is $99/month and compounded tirzepatide $125/month on annual plans, held flat at every dose. One membership covers medication, clinician visits, check-ins and free shipping, with no separate fees. A month-to-month rate is not published.
Which pharmacies does Trimi use?
VialsRx and GreenwichRx, both described as state-licensed 503A compounding pharmacies. Naming them puts Trimi ahead of most competitors at this price.
Is Trimi legit?
Its disclosures are the kind a legitimate operator makes — named pharmacies, a named provider network with named physicians, published state coverage and a correct statement of regulatory status. The caveat is not legitimacy but evidence: the independent review sample is small and there is no BBB profile.
Does the price rise as my dose increases?
No. Trimi commits to the same price at every dose, which is one of its better features — particularly on tirzepatide, where dose-based pricing elsewhere gets expensive fast.
What is the refund policy?
Trimi states that if you follow your plan for six months and do not lose weight, you can request a refund, subject to its published refund policy. It requires six months of adherence first, so it is not a short-term money-back guarantee.
Is Trimi's semaglutide the same as Wegovy?
No. It shares an active ingredient, but compounded products are not FDA-approved and have not been evaluated for safety, efficacy or quality. Trimi states this correctly on its site. The FDA has warned other telehealth companies specifically about "same active ingredient" marketing implying approval.
Which states does Trimi serve?
All 50 states, through the Arora Health provider network.
Verdict
3.6 / 5
The best-disclosed cheap GLP-1 provider we have reviewed — named pharmacies, named physicians, honest regulatory language and $125 tirzepatide — rated down only because the annual commitment comes with almost no independent track record to justify it.
Trimi does the things we spend most of these reviews complaining that companies do not do. It tells you which pharmacy compounds your medication, which doctors run its clinical network, which states it serves and what the regulatory status of its product actually is. At $125 for tirzepatide held flat at every dose, the offer is excellent. The reservation is straightforward and not a criticism of the company's conduct: it is asking for a twelve-month commitment on the strength of a few dozen reviews and no BBB file. If you are comfortable with that trade, this is a well-run-looking service at a very good price. If you are not, wait six months and look again.
Medical Disclaimer & Review Date
This review is general consumer information, not medical advice. GLP-1 medications are prescription drugs with serious contraindications, and whether any treatment is appropriate for you is a decision only a licensed healthcare provider who knows your medical history can make. Nothing here should be used to start, stop, or change a medication.
Details in this review come from Trimi Health's own published materials as of the date below. Pricing, medication availability, state coverage, and policies in this category change frequently — verify current terms directly with the provider before purchasing.
Date reviewed: August 6, 2026
Check the Commitment Before the Price
The $99 and $125 rates are annual-plan pricing. Confirm the cancellation terms and whether a month-to-month option exists before committing for a year.